Author | Wayne Kuznar


Litoxetine reduces rate of incontinence episodes

July 23, 2020


Treatment with litoxetine, an investigational oral selective serotonin reuptake inhibitor, led to nearly 22% of patients becoming continent.

Improvement in LUTS with aquablation maintained to 2 years with lower risk of sexual dysfunction versus TURP

July 22, 2020


Retreatment rates were low with both aquablation and transurethral resection of the prostate.

Prostate cancer treatments have differential effect on quality of life, survey indicates

July 21, 2020


The EUPROMS patient-driven quality-of-life study included data from almost 3000 men treated for prostate cancer.

18F-DCFPyL–PET/CT demonstrates effective diagnostic performance in biochemically recurrent prostate cancer

July 15, 2020


The phase 3 CONDOR study demonstrated excellent diagnostic performance with 18F-DCFPyL–PET/CT in men with biochemically relapsed prostate cancer, even at very low PSA values.